CORPORATE GOVERNANCE | 2026-10-11

Enhanced Scrutiny of Takeover Defenses: How Unocal and Unitrin Govern a Delaware Board’s Response to a Hostile Bid

When a board adopts a poison pill or other defense against a takeover, Delaware does not simply defer to it — nor does it second-guess every judgment. It applies enhanced scrutiny: the board must show a reasonable threat and a proportionate response. Unocal and Unitrin built that framework, and it still governs hostile-bid fights.

By Anatolii Trembach, Esq. (California State Bar No. 349304; LL.M., USC Gould School of Law; admitted to the U.S. Court of International Trade), Trembach Law Firm, APC · Published

When a company faces a hostile takeover bid and its board responds with a defensive measure — a poison pill (shareholder rights plan), a staggered board, or a restructuring — the board occupies an inherently conflicted position: the defense protects the company, but it also protects the directors’ o

A hostile takeover pits a bidder who wants to buy a company against a board that does not want to sell — or does not want to sell to this bidder, on these terms, now. The board holds powerful defensive tools, chief among them the poison pill, which can make an unwanted acquisition prohibitively dilutive. But those same tools can entrench directors against the will of shareholders who might prefer to take the bidder's money. Delaware's answer is neither blind deference nor aggressive second-guessing, but a calibrated middle standard that forces the board to justify its defense. Understanding that standard is essential for any shareholder weighing a hostile bid and for any company contemplating its defenses.

Why Delaware Law Controls for California Investors

Under the internal affairs doctrine, which California courts follow, the conduct of a corporation's directors toward its shareholders is governed by the law of the state of incorporation. Because most large public companies are incorporated in Delaware, a California shareholder evaluating a board's takeover defense is almost always looking at Delaware law — Unocal, Unitrin, and their progeny — not California corporate statutes. That is why these Delaware Supreme Court decisions matter directly to California investors, and why a shareholder contesting an entrenching defense must frame the challenge in Delaware's terms.

The Business Judgment Rule and Why Takeover Defenses Are Different

Ordinarily, Delaware reviews board decisions under the deferential business judgment rule, presuming directors acted on an informed basis, in good faith, and in the honest belief the action served the company. But the Unocal court recognized that defensive measures present a special problem: "because of the omnipresent specter that a board may be acting primarily in its own interests," there is an "enhanced duty" before the usual deference applies. The board facing a takeover has an inherent, structural conflict — its defense may serve shareholders, or may serve the directors' desire to keep their positions. Enhanced scrutiny exists to police that conflict without paralyzing legitimate defense. It is an intermediate standard: more demanding than business judgment, less demanding than entire fairness.

The Two-Part Unocal Test

Unocal established a two-part test that the board must satisfy to earn business-judgment protection for a defensive measure. First, the board must show it had reasonable grounds to believe a danger to corporate policy and effectiveness existed — the "threat" prong. The board satisfies this by showing good faith and reasonable investigation, and the showing is materially enhanced when a majority of the board is independent. Second, the board must show that the defensive response was reasonable in relation to the threat posed — the "proportionality" prong. A response that is draconian, in the sense of being coercive or preclusive, fails; a response within a "range of reasonableness" passes. The genius of the test is that it requires the board to identify a real threat and to tailor its defense to that threat, rather than simply blocking any and all bids. If the board cannot carry both prongs, its defense loses the protection of the business judgment rule and becomes vulnerable to challenge.

Unitrin and the Meaning of "Proportionate"

Unitrin, Inc. v. American General Corp. sharpened the proportionality prong. The court explained that a defensive measure is disproportionate — and therefore impermissible — if it is either coercive (it crams a management-sponsored alternative down shareholders' throats) or preclusive (it makes a successful proxy contest or bid realistically unattainable). If the measure is neither coercive nor preclusive, the court then asks whether it falls within a range of reasonable responses to the threat, and if so, defers to the board's judgment. Unitrin thus created a structured inquiry: first test for coercion and preclusion as threshold disqualifiers, then evaluate reasonableness. This framework gives boards meaningful room to defend the company while drawing a firm line at defenses that disenfranchise shareholders or foreclose their ability to decide for themselves. For a shareholder challenging a defense, the most powerful arguments are usually that the measure is preclusive — that it makes it effectively impossible to win a proxy fight or complete a bid.

The Poison Pill: Moran and Its Limits

The signature takeover defense is the poison pill, or shareholder rights plan, which Delaware first upheld as a legitimate defensive tool in Moran v. Household International, Inc. (1985) 500 A.2d 1346. A pill typically gives existing shareholders the right to buy stock at a steep discount if a hostile acquirer crosses an ownership threshold, massively diluting the acquirer and making the takeover economically prohibitive. Moran held that adopting a pill is within a board's authority, but it also held that the board's use of the pill — including its decision whether to redeem (pull) the pill in the face of a specific bid — remains subject to Unocal scrutiny. In other words, a board may keep a pill in its pocket, but when a real bid arrives, its refusal to redeem must satisfy the reasonableness and proportionality tests. The pill does not give the board absolute veto power; it gives the board time and leverage, subject to judicial review of how that leverage is used. This is why hostile-bid litigation so often focuses on whether the board will be ordered to redeem a pill that is blocking a fully financed, non-coercive offer.

Where Unocal Shades Into Revlon

Enhanced scrutiny under Unocal governs defensive conduct, but a related standard governs a board that has decided to sell. Once a company is in a sale or break-up that will result in a change of control, the board's duty shifts to obtaining the best value reasonably available for shareholders — the Revlon duty we discuss in our article on Revlon duties in a sale of control. The line between the two can be decisive: a board defending the company's independence is judged under Unocal, while a board selling control is judged under Revlon. The Delaware Supreme Court has policed this boundary in landmark cases — upholding a board's defense of a long-term strategic plan in one setting while requiring value-maximization once a sale of control was underway in another. For shareholders, identifying which standard applies is the first analytical step, because it determines what the board was actually required to do. A board that treats a sale-of-control situation as if it were merely defending independence may breach its Revlon duty; a board that is genuinely defending independence is entitled to the room Unocal provides.

Disclosure and the Shareholder Franchise

Takeover fights are often decided not only by defensive mechanics but by shareholder votes — in proxy contests to replace the board, or in votes on a merger. Delaware law protects the shareholder franchise closely, and board action that interferes with a fair vote draws especially careful review. Measures that manipulate the timing or conduct of an election to entrench the incumbent board can be struck down even apart from Unocal, under the principle that the vote is the ideological underpinning of the board's legitimacy. Disclosure obligations also run throughout: when a board asks shareholders to reject a bid or support a defensive transaction, it must disclose fully and fairly the material facts bearing on that decision. A board that defends the company while withholding material information, or that structures a defense to disenfranchise shareholders, exposes itself to challenge on multiple fronts. These franchise and disclosure principles often work together with Unocal to constrain a board's defensive playbook.

The Omnipresent Specter and the Role of Independent Directors

At the heart of enhanced scrutiny is what Unocal called the "omnipresent specter that a board may be acting primarily in its own interests" when it resists a takeover. That concern is why the composition of the deciding board matters so much. Delaware courts give a defensive decision far more credence when it is made or approved by a board composed of a majority of independent, outside directors acting in good faith after reasonable investigation. Independent directors have no job to protect in the way management does, so their endorsement of a defense helps rebut the inference that the defense is entrenchment. Conversely, a defense driven by conflicted insiders — directors whose positions, compensation, or relationships are tied to the status quo — invites skepticism and makes the board's burden harder to carry. For a shareholder challenging a defense, scrutinizing who actually decided, how independent they were, and what investigation they conducted is often as important as analyzing the defensive measure itself. For a board, building a genuinely independent, well-informed decision-making process is the single most effective way to earn the court's deference under Unocal, because it directly answers the conflict concern the standard exists to police.

Deal-Protection Devices and the Reach of Enhanced Scrutiny

Enhanced scrutiny extends beyond classic anti-takeover defenses to the deal-protection devices a board agrees to when it signs a favored merger — termination fees, no-shop and no-talk clauses, matching rights, and voting agreements that lock up a transaction. These devices protect a signed deal, but taken too far they can preclude a superior competing bid and disenfranchise shareholders, raising the same proportionality concerns as a poison pill. Delaware courts have struck down deal-protection packages that, in combination, were so onerous as to be preclusive or coercive — foreclosing any realistic possibility of a better offer or effectively compelling shareholder approval. The analysis mirrors Unitrin's: a reasonable set of protections that a target gives to induce a bidder to commit is permissible, but a package that forecloses the shareholders' ability to consider alternatives is not. This matters because many modern control contests are fought not over a bare poison pill but over whether a board bargained away too much to protect a preferred deal. A shareholder who believes a board has over-protected a transaction at the expense of a better alternative can invoke the same enhanced-scrutiny framework to challenge the lockups, and a board negotiating a merger must keep the devices within the range that enhanced scrutiny will tolerate.

What This Means for California Shareholders and Companies

For a California shareholder, enhanced scrutiny is the doctrinal key to challenging an entrenching defense. If a board is refusing to redeem a pill against a fully financed, non-coercive, premium bid, or has erected defenses that make a proxy contest realistically unwinnable, Unocal and Unitrin supply the framework for arguing the defense is unreasonable or preclusive. For a California company and its board, the same framework is a roadmap for defending the company lawfully: identify a genuine threat, investigate it in good faith with an independent board, and tailor a response that is neither coercive nor preclusive and that falls within a range of reasonableness. In both directions, the analysis is fact-intensive and time-sensitive — hostile-bid litigation moves fast, often on expedited schedules in the Court of Chancery. Whether you are a shareholder seeking to hold a board to account or a company seeking to defend itself within the law, early, informed analysis of the Unocal/Unitrin standard is essential, because the window to act in a control contest is short and the stakes — control of the company and the value of every share — are large.

A final practical point deserves emphasis: control contests are won and lost on speed and preparation. Because defensive measures can be deployed in days and the Court of Chancery hears these disputes on expedited schedules, a shareholder who waits to analyze a board's response, or a board that improvises a defense without a documented, independent process, is at a serious disadvantage. The doctrine rewards the party that has already done the work — the shareholder who can articulate precisely why a defense is preclusive or coercive, and the board that can show a genuine threat, a real investigation, and a proportionate, carefully considered response. Enhanced scrutiny is ultimately a demand for justification, and justification cannot be assembled after the fact under deadline pressure. Understanding the standard before a bid arrives, and acting within its framework once one does, is what separates a defensible position from a vulnerable one on either side of a takeover fight.

Frequently Asked Questions

What is enhanced scrutiny?

It is Delaware's intermediate standard of review for board defensive measures in a takeover context, from Unocal v. Mesa Petroleum. It is more demanding than the business judgment rule but less demanding than entire fairness, and it exists because a board defending against a takeover has an inherent conflict between protecting the company and protecting its own positions.

What is the two-part Unocal test?

First, the board must show reasonable grounds to believe a threat to corporate policy existed (the threat prong), a showing strengthened by an independent board acting in good faith after reasonable investigation. Second, it must show the defensive response was reasonable in relation to the threat (the proportionality prong).

How did Unitrin refine the test?

Unitrin held that a defensive measure is disproportionate if it is coercive (forcing a management alternative on shareholders) or preclusive (making a proxy contest or bid realistically unattainable). If it is neither, the court asks whether it falls within a range of reasonable responses and, if so, defers to the board.

Is a poison pill legal?

Yes. Delaware upheld the poison pill as a legitimate defensive tool in Moran v. Household International (1985). But a board's use of the pill — including its refusal to redeem it against a specific bid — remains subject to Unocal scrutiny. The pill gives the board time and leverage, not an absolute veto.

What is the difference between Unocal and Revlon?

Unocal governs a board defending the company's independence; Revlon governs a board that has decided to sell or break up the company, requiring it to obtain the best value reasonably available for shareholders. Which standard applies depends on whether the company is defending independence or selling control.

When can a defense be struck down?

When the board cannot show a reasonable threat, or when the response is coercive, preclusive, or outside the range of reasonableness. Defenses that disenfranchise shareholders or entrench directors against a fair vote are especially vulnerable, sometimes on franchise grounds independent of Unocal.

Does Delaware law apply if the company operates in California?

Yes, if it is incorporated in Delaware. Under the internal affairs doctrine, which California follows, the law of the state of incorporation governs directors' duties to shareholders, so a California investor evaluates a takeover defense under Delaware's Unocal and Unitrin framework.

I think a board is entrenching itself against a good offer. What can I do?

Enhanced scrutiny gives you a framework to challenge the defense as unreasonable or preclusive, often on an expedited basis in the Court of Chancery. Because control contests move quickly, act promptly. Call Trembach Law Firm at (818) 514-7680 for an evaluation.

Talk to a California Corporate Lawyer About a Takeover Defense

When a board adopts or refuses to redeem a takeover defense, Delaware's enhanced-scrutiny standard — built on Unocal, Unitrin, and Moran — decides whether the defense protects shareholders or entrenches the board. Trembach Law Firm, led by Anatolii Trembach (LL.M.; admitted in California), helps California shareholders challenge coercive or preclusive defenses and helps companies defend themselves within the law, applying the reasonableness and proportionality tests that govern every hostile-bid contest. Call (818) 514-7680 for a confidential consultation.

Contact Trembach Law Firm at (818) 514-7680 for a confidential consultation.

Trembach Law Firm | 27001 Agoura Road, Suite 350, Calabasas, CA 91301